Bottom line
TARK vs SPXL: the short answer
TARK (Tradr 2X Long Innovation ETF) and SPXL (Direxion Daily S&P 500(R) Bull 3X ETF) are both etfs.
But SPXL is far broader, holding 515 positions to 4 for TARK, so beyond the top names it adds exposure TARK doesn't have.
SPXL is cheaper at 0.84% vs 1.48% — a difference of $64 a year per $10,000 invested.
Over one year, TARK returned +41.5% vs +32.1% for SPXL.
Updated Nov 19, 2026
TARK vs SPXL side by side
| TARK | SPXL | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | First Trust | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.48% | 0.84% |
| Annual cost per $10k | $148 | $84 |
| 10-yr cost on $10k (prospectus) | $2,070 | $1,156 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +41.5% | +32.1% |
| 5-yr return (annualized) | — | +25.8% |
| 10-yr return (annualized) | — | +27.9% |
| Best quarter | +98.5% | +60.9% |
| Worst quarter | −34.8% | −60.5% |
| Net assets (fund) | $19.5M | $6.7B |
| Number of holdings | 4 | 515 |
| Portfolio turnover | % | 71% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | TARK | SPXL | Difference |
|---|---|---|---|
| 2025 | +41.5% | +32.1% | +9.4% |
| 2024 | −4.9% | +63.6% | −68.5% |
| 2023 | +119.9% | +69.2% | +50.7% |
Source: Fund prospectus bar charts
Holdings overlap
TARK and SPXL share none of their top holdings.
TARK top 10
- Cfd Ark Innovation ETF — 33.03%
- Cfd Ark Innovation ETF — 7.51%
- Cfd Ark Innovation ETF — 4.06%
- Cfd Ark Innovation ETF — -0.22%
SPXL top 10
- Dreyfus — 10.22%
- Dreyfus — 6.74%
- Nvidia Corp — 5.65%
- Apple Inc — 5.27%
- Microsoft Corp — 4.01%
- Goldman Financial — 3.82%
- Amazon.com Inc — 3.09%
- N/a — 2.89%
- N/a — 2.47%
- Alphabet Inc — 2.43%
FAQ
What is the difference between TARK and SPXL?
Which is cheaper, TARK or SPXL?
Should I own both TARK and SPXL?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.